Direct Conjugation of Emerging Contaminants in ... - ACS Publications

Subscriber access provided by UB + Fachbibliothek Chemie | (FU-Bibliothekssystem)

Article

Direct Conjugation of Emerging Contaminants in Arabidopsis: Indication for an Overlooked Risk in Plants? Qiuguo Fu, Jianbo Zhang, Dan Borchardt, Daniel Schlenk, and Jay J. Gan Environ. Sci. Technol., Just Accepted Manuscript • Publication Date (Web): 14 May 2017 Downloaded from http://pubs.acs.org on May 14, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Environmental Science & Technology is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 42

Environmental Science & Technology

TOC Art

ACS Paragon Plus Environment


1

Direct Conjugation of Emerging Contaminants in Arabidopsis: Indication for an

2

Overlooked Risk in Plants?

3

Qiuguo Fu,†,‡ Jianbo Zhang,§ Dan Borchardt,¶ Daniel Schlenk,† and Jay Gan†,*

4 5 6 7 8 9 10 11 12

†

Department of Environmental Sciences, University of California, Riverside, California 92521,

United States ‡

Eawag, Swiss Federal Institute of Aquatic Science and Technology Environmental Chemistry,

8600 Dübendorf, Switzerland §

Department of Health Sciences and Technology, Institute of Food, Nutrition and Health, ETH,

8092 Zürich, Switzerland ¶

Department of Chemistry, University of California, Riverside, California 92521, United States

13 14 15 16 17 18 19

Word count: Text (5452) + Figure (4×300) + Table (1×300) = 6952

20 21

1


Page 2 of 42

Page 3 of 42


22

ABSTRACT

23

Agricultural use of treated wastewater, biosolids and animal wastes introduces a multitude of

24

contaminants of emerging concerns (CECs) into the soil-plant system. The potential for food

25

crops to accumulate CECs depends largely on their metabolism in plants, which at present is

26

poorly understood. Here we evaluated the metabolism of naproxen and ibuprofen, two of the

27

most used human drugs from the profen family, in Arabidopsis thaliana cells and Arabidopsis

28

plant. The complementary use of high-resolution mass spectrometry and 14C labeling allowed

29

characterization of both free and conjugated metabolites, as well as non-extractable residues.

30

Naproxen and ibuprofen, in their parent form, were conjugated quickly and directly with

31

glutamic acid and glutamine, and further with peptides, in A. thaliana cells. For example, after

32

120 h, the metabolites of naproxen accounted for >90% of the extractable chemical mass, while

33

the intact parent itself was negligible. The structures of glutamate and glutamine conjugates were

34

confirmed using synthesized standards, and further verified in whole plants. Amino acid

35

conjugates may easily deconjugate, releasing the parent molecule. This finding highlights the

36

possibility that the bioactivity of such CECs may be effectively preserved through direct

37

conjugation - a previously overlooked risk. Many other CECs are also carboxylic acids like the

38

profens. Therefore, direct conjugation may be a common route for plant metabolism of these

39

CECs, making it imperative to consider conjugates when assessing their risks.

40 41

Keywords: Contaminants of emerging concern; amino acid conjugation; water reuse;

42

pharmaceuticals; naproxen; ibuprofen

43

2



44

INTRODUCTION

45

Many countries and regions are experiencing unprecedented water scarcity due to

46

population growth, urbanization, and climate change-induced disruptions in precipitation

47

patterns, prompting the search for alternative water sources.1 Reuse of municipal wastewater for

48

agricultural irrigation directly alleviates pressure on freshwater supplies, and indirectly

49

replenishes groundwater storage via percolation.2 However, treated wastewater is known to

50

contain many contaminants of emerging concern (CECs), including disinfection byproducts,

51

pharmaceuticals and personal care products, and endocrine disrupting compounds. Additionally,

52

large amounts of biosolids and animal wastes, which also contain numerous CECs, are

53

increasingly recycled back into agricultural fields as fertilizers.3 These practices inevitably

54

introduce CECs into the soil-plant system, posing the possibility for some CECs to enter the

55

terrestrial food chains, including the human diet.4–6

56

Studies over the last decade show that plants are capable of accumulating CECs from

57

soil, but the levels in edible tissues are relatively low under realistic conditions.1,7,8 However, in

58

these studies, researchers almost always targeted only the parent compound for analysis, while

59

neglecting metabolites, particularly conjugates that may have biological activity.8,9 Previous

60

research on xenobiotics such as pesticides shows that plants can transform man-made chemicals

61

through Phase I, II and III metabolism.9–11 Phase II metabolism is characterized with conjugation

62

of parent or metabolites with sugars, sulfates, and amino acids.12–14 Moreover, such conjugates

63

may readily undergo cleavage through enzymatic hydrolysis (e.g., in human gut), releasing

64

xenobiotics in the free form that may subsequently elicit biological responses.15 Therefore, a

65

comprehensive risk assessment of CECs in the soil-plant system should consider metabolic

66

transformations, especially conjugation, in plants.

3


Page 4 of 42

Page 5 of 42


67

The goal of this study was to elucidate the biotransformation of CECs in plants to better

68

understand their risks in the waste reuse-food safety nexus. We used naproxen and ibuprofen as

69

model CECs to explore their metabolic fate in Arabidopsis. Naproxen and ibuprofen belong to

70

the profen family of the non-steroidal anti-inflammatory drugs, and are among the most

71

consumed human medicines.16 Like many other CECs, naproxen and ibuprofen are not

72

completely removed at wastewater treatment plants (WWTPs),17 resulting in their ubiquitous

73

occurrence in aquatic environments.18–20 For example, naproxen and ibuprofen were detected in

74

WWTP and hospital effluents at levels up to 11 µg L-1 and 151 µg L-1, respectively.21,22

75

In a recent study, low levels of naproxen and ibuprofen were detected in several

76

vegetables grown with treated wastewater irrigation under field conditions.1 When cultivated

77

hydroponically, naproxen and ibuprofen disappeared quickly from the nutrient media, but only

78

trace amounts of the parent were found in plant tissues,23 implying that they were converted to

79

other forms in the plant. Staswick et al. discovered that Arabidopsis was capable of conjugating

80

endogenous carboxylic acids with a number of amino acids.24 Here we hypothesized that in

81

plants, CECs with a carboxyl group, which encompass a large number of compounds, may form

82

conjugates with plant biomolecules. If this pathway is prevalent, the biological activity of these

83

contaminants may be effectively preserved, highlighting the importance to consider conjugates

84

when predicting adverse risks of CECs.

85 86 87

MATERIALS AND METHODS Chemicals. [Methoxy-14C]-Naproxen ((S)-6-methoxy-α-methyl-2-naphthaleneacetic

88

acid, radiochemical and chemical purity >99%, specific activity 55 mCi/mmol) was purchased

89

from American Radiolabeled Chemicals (Saint Louis, MO). Non-labeled naproxen and ibuprofen

4



90

were obtained from Alfa Aesar (Ward Hill, MA). d3-Naproxen and d3-ibuprofen were obtained

91

from C/D/N Isotopes (Pointe-Claire, Quebec, Canada). Standard of 6-O-desmethylnaproxen was

92

acquired from Toronto Research Chemicals (Toronto, Ontario, Canada). Standards of glutamic

93

acid and glutamine conjugates of naproxen and ibuprofen were obtained through custom

94

synthesis (Biosynthesis, Lewisville, TX). All other chemicals were purchased from Fisher (Fair

95

Lawn, NJ). Ultrapure water was prepared using a Barnstead E-Pure water purification system

96

(Thermo Scientific, Dubuque, IA).

97

Arabidopsis thaliana Cell Line. The A. thaliana cell line PSB-D was provided by the

98

Arabidopsis Biological Resource Center at Ohio State University (Columbus, OH). Cells were

99

cultured in suspension at 25 °C and 130 rpm in the dark based on the supplier’s instructions.

100

Details on the medium composition and preparation are given in Text S1 in Supporting

101

Information (SI).

102

Incubation Experiments and Treatments. Active cells of A. thaliana were inoculated

103

into fresh culture medium (10%, v/v), followed by incubation in the dark at 25 °C and 130 rpm

104

for 4 d. An aliquot of 20 µl stock solution of 14C-naproxen (3.8 × 106 dpm) was spiked to the cell

105

culture to yield an initial chemical concentration of 2.0 ± 0.05 µg mL-1. The use of such a

106

relatively high concentration was to facilitate the identification of metabolites.21,22 For ibuprofen,

107

only non-labeled standard was used. Several control treatments were included for quality control,

108

including a blank cell culture control with A. thaliana cells only, a carrier solvent control with A.

109

thaliana cells spiked with 20 µl methanol (i.e., without chemical), a medium control with

110

naproxen (or ibuprofen) but without cells, and a medium control with non-viable cells

111

(autoclaved at 121 °C for 45 min) similarly spiked with 14C-naproxen.

112

Sample Preparation and Analysis. At 0, 6, 12, 24, 48, 96, and 120 h into the incubation,

5


Page 6 of 42

Page 7 of 42


113

cells were immediately separated from the medium by centrifugation at 3000 rpm for 30 min. A

114

0.5 mL aliquot of supernatant was mixed with 4 mL UltimaGold cocktail to measure 14C

115

radioactivity on a PerkinElmer TriCarb liquid scintillation counter (LSC). The remaining

116

supernatant was added with 50 µL of 10 mg L-1 d3-naproxen (or d3-ibuprofen) as surrogate, and

117

the mixture was passed through a 150-mg HLB cartridge (Waters, Milford, MA) pre-conditioned

118

with 7-mL methanol and 7-mL ultrapure water. The analytes were eluted with 20 mL methanol

119

and reconstituted in 1.5 mL methanol after drying under N2.

120

The cell matter after centrifugation was collected and freeze-dried, followed by

121

sequential extractions and cleanup. Briefly, 0.10 g of the freeze-dried cells was spiked with 50

122

µL of 10 mg L-1 d3-naproxen (or d3-ibuprofen), followed by extraction with 20 mL of methanol

123

(twice) and acetonitrile (twice) in a sonication water bath. The extracts were pooled after

124

centrifugation (30 min at 3000 rpm) and reconstituted in 1.0 mL methanol after drying under N2.

125

A 20-µL aliquot of the final extract was measured for 14C radioactivity by LSC and defined as

126

the extractable residue (ER). The remaining extract was diluted with 20 mL ultrapure water and

127

passed through a 150-mg HLB cartridge (Waters, Milford, MA) for cleanup, as described above.

128

The final samples were centrifuged at 12,000 rpm for 10 min (Eppendorf 5840R, Wesseling-

129

Berzdorf, Germany) and filtered through a 0.22-µm polytetrafluoroethylene (PTFE) membrane

130

(Millipore, Carrigtwohill, Cork, Ireland) to remove solids. The final samples were stored at -

131

20 °C before analysis. The recoveries of naproxen and ibuprofen, as determined using the

132

deuterated surrogate, ranged from 76% to 94%, suggesting the overall effectiveness of the above

133

extraction procedure. More details on the recovery determination is provided as Text S2 in the

134

Supporting Information (SI).

135

To quantify the non-extractable residue, the cell matter after the sequential extractions

6



136

was dried in the fume hood and then combusted on a Biological Oxidizer OX500 (R. J. Harvey

137

Instruments, Hillsdale, NJ). The released 14CO2 was trapped in 15 mL Harvey Carbon-14

138

Cocktail (R. J. Harvey) and the radioactivity was determined on LSC. The catalyst temperature

139

was 680 °C, the combustion temperature 900 °C and the combustion cycle was 4 min. The

140

recovery of the combustion procedure for 14C was determined to be 92.7 ± 2.6% (n= 3) using

141

standards.

142

UPLC-QqQ-MS/MS and LC-TOF-HRMS. The samples after SPE cleanup were

143

analyzed first on LC-TOF-HRMS to obtain the overall metabolic profile and identify metabolite

144

candidates after cross-comparison between the treatment and controls. The metabolite

145

candidates, together with the parent compound, were further analyzed on UPLC-QqQ-MS/MS in

146

different scan modes, including product ion scan, neutral loss scan, and multiple reactions

147

monitoring (MRM).

148

For the LC-TOF-HRMS analysis, an Agilent 1200 LC system coupled to Agilent 1200

149

series UV detector and an Agilent 6210 time-of-flight (TOF) mass spectrometer was used, and

150

the separation was achieved on an ACQUITY UPLC BEH C18 column (2.1 mm x 100 mm, 1.7

151

µm particle size, Waters) at 40 °C. Water (containing 5% methanol and 0.001% formic acid) and

152

methanol were used as the mobile phases A and B, respectively, which was programmed as

153

below (with respect to e B): 0-1 min, 5% to 50%; 1-17 min, 50 to 100%; 17-27 min, 100%; 28-

154

30 min, 100 to 5%; and 30-32 min, 5%. The flow rate was 0.17 mL/min and the injection volume

155

was 5 µL. The UV absorbance was recorded at 232 nm. The instrument control and data

156

acquisition were carried out with the MassHunter workstation software (Version B.01.03,

157

Agilent). The instrumental settings for TOF-HRMS were as follow: capillary voltage 2.5

158

kV, nebulizer 60 psig, drying gas 6 L/min, gas temperature 200 °C, fragmentor 115

7


Page 8 of 42

Page 9 of 42


159

V, skimmer 60 V, Oct dc1 37.5 V, and Oct rf V 250 V. The mass axis was calibrated using the

160

mixture provided by the manufacturer over the m/z 100 – 3200 range. Spectra were acquired in

161

the electrospray ionization (ESI) negative mode over m/z 100−1700 Da, a scan rate of 1 scan/s

162

and resolution of 10,000.

163

For UPLC-QqQ-MS/MS analysis, samples were injected into a Waters ACQUITY ultra-

164

performance liquid chromatography (UPLC) combined with a Waters Micromass Triple

165

Quadrupole mass spectrometer (QqQ-MS) equipped with an electron spray ionization (ESI)

166

interface (Waters, Milford, MA). Separation was achieved on the same column and with mobile

167

phases as described above. The injection volume was 5 µL and flow rate was 0.2 mL min-1. The

168

MRM transitions of authentic standards of naproxen, d3-naproxen, desmethyl-naproxen,

169

ibuprofen and d3-ibuprofen were optimized and are summarized in Table S1. The specific

170

instrument settings were: capillary voltage 3.2 kV, cone voltage 30 V, collision gas (Argon,

171

99.99%) 0.2 ml/min, dwell time 0.02 s, source temperature 120 °C, desolvation temperature

172

350 °C, desolvation gas 600 L h-1 and cone gas 50 L h-1. The cone voltage (V) and collision

173

energy (eV) for each target analyte were optimized and are described in Supporting Information.

174

Candidate Identification. Raw data files were converted to mzXML files with

175

msConvert by PreoteoWizard25 and subsequently analyzed using the MZmine 2 software.26 The

176

presence, peak areas, retention times, and exact m/z in the different treatments were analyzed and

177

compared via MZmine according to the manual. Candidate metabolites were proposed in

178

accordance with their unique presence in the treatment and absence in all controls. At identical

179

retention times, characteristic natural isotopes were considered in structural elucidation. The

180

possible chemical formula for metabolite candidates and the error of mass accuracy in part per

181

million (ppm) were obtained using the Agilent Mass Hunter. After preliminary identification of

8



182

candidate metabolites, the data were further confirmed by LC-QqQ-MS in the product ion scan,

183

neutral loss scan, and MRM scan mode. The main fragmentation patterns were acquired to

184

ascertain the structures of candidate metabolites by comparing with the database. Authentic

185

standards were used to confirm the proposed structures, when available. In addition to the parent

186

compound, custom synthesized standards of glutamic acid and glutamate conjugates of naproxen

187

or ibuprofen were used in this study to confirm the structure of the proposed conjugates by cross

188

comparison. Retention times, accurate masses, and fragmentation patterns were cross-compared

189

for unambiguous identification. Validation in Whole Plants. The metabolites were further validated in the whole plants

190 191

of two wild-type A. thaliana, i.e., Col-0 and Ler-0, grown in a hydroponic system. In brief, wild-

192

type A. thaliana seedlings were exposed to naproxen at 1.0 mg L-1 in the nutrient solution. After

193

4 d of exposure, the whole plants and nutrient medium were separately harvested. The

194

preparation of plant and growth medium samples was the same as described above for cell

195

cultures. LC-QqQ-MS/MS was used to target screen the proposed metabolites in the MRM

196

mode.

197

Statistical Analysis. Data are presented as mean ± standard deviation (SD). One-way

198

analysis of variance (ANOVA) and Student’s t-test were carried out with GraphPad 6 to evaluate

199

systematic differences among treatments and between two groups, respectively (α = 0.05).

200 201 202

RESULTS Dissipation of Parent Compound in Cell Culture. Both naproxen and ibuprofen were

203

considered in similar experiments and subjected to similar analyses. To streamline discussion,

204

here we focus on naproxen results in the main text, and present the findings on ibuprofen in SI.

9


Page 10 of 42

Page 11 of 42

205


To affirm biotransformations of naproxen in A. thaliana cells, negative and positive

206

controls underwent the same handling and analytical procedures. In the control with non-viable

207

cells and cell-free medium, no apparent disappearance of naproxen occurred after the 120-h

208

incubation, indicating absence of abiotic transformation or adsorption onto the non-viable cells

209

(Figure 1A). However, in the presence of viable A. thaliana cells, naproxen quickly dissipated in

210

the medium. For example, naproxen concentration in the medium decreased from 2058 ± 290 ng

211

mL-1 initially to 61.5 ± 19.2 ng mL-1 at 6 h, to 0.6 ± 0.2 ng mL-1 at 24 h, and remained at a

212

negligible level until the end of 120-h incubation (Figure 1A). Fitting naproxen concentrations in

213

the medium to a first-order decay model resulted in a half-life of only 1.6 h. As abiotic

214

transformation or adsorption was negligible, naproxen disappearance in the medium containing

215

viable cells may be attributed to uptake and subsequent biotransformation by A. thaliana cells.

216

Figure 1B shows that naproxen appeared in the cells and that the level was the highest

217

after 6 h of incubation (the first sampling interval), providing direct evidence for its uptake into

218

A. thaliana cells. The concentration of naproxen in the cells, however, rapidly decreased as the

219

incubation time further increased and became negligible after 48 h (Figure 1B). Moreover, even

220

at 6 h, the amount of naproxen in the A. thaliana cells, in the parent form, accounted for only 1.0

221

± 0.1% of the spiked amount. This large discrepancy in mass balance implied that naproxen was

222

quickly and nearly completely converted to other forms from its parent form in the culture.

223

Formation of Metabolites of Naproxen. Eleven metabolites of naproxen in A. thaliana

224

cells were identified using LC-TOF-HRMS and UPLC-QqQ-MS/MS (Table 1 and Figure S1,

225

Figure S2). The identification was based on the following criteria commonly used for metabolite

226

identification27–31: a) error of measurement accuracy is < 5 ppm for [M-H] and [M+1-H]; b)

227

difference of observed and calculated isotopic abundance is < 1.5%; c) the calculated empirical

10



228

formula obeys the nitrogen rule;32 d) fragmentation pattern matches reported data in literature or

229

database, or could be adequately explained; and e) retention time (tR) is identical to that of a

230

standard, if available.

231

The naproxen parent molecule was confirmed against its standard in LC-TOF-HRMS,

232

giving an accurate mass to charge ratio (m/z) of 229.0837 and a predicted [M-H] formula of

233

C10H9ON6. Further fragmentation gave fragments at m/z 185, 170, and 169, and the pattern was

234

consistent with those in the database (MassBank record KO001524). The demethylated product,

235

i.e., 6-O-desmethyl-naproxen, was observed and further confirmed with an authentic standard

236

(Table S1, Figure S2). Therefore, according to the scheme proposed by Schymanski et al.,33

237

naproxen and 6-O-desmethyl-naproxen achieved Level 1 unambiguous confirmation and they

238

may be considered as “confirmed” structures.

239

The metabolites N357 and N358 were identified via HRMS, fragmentation patterns,

240

literature and database searching, and directly confirmed with custom-synthesized standards

241

(Table 1, Text S2, Table S2-3, Figure S3-5). The accurate measurement of m/z of N357 (m/z

242

357.1455, tR = 9.3 min) gave the predicted [M-H] formula of C19H21N2O5 with an error of 0.15

243

ppm (Table 1), and the isotopic abundance difference (∆abundance) of [M+1-H] was 0.69%

244

(Table S2). In addition, N357 was found to produce fragments at m/z 185, 170, 145, 128, 127,

245

109, 84, and 74. The fragments of m/z 185 and 170 were the same as naproxen and suggested the

246

presence of naproxen analog in the metabolite (Table 1). Meanwhile, the fragments at m/z 145,

247

128, 127, 109, 84, and 74 were consistent with those of glutamine (Gln) as in the MassBank

248

database (Figure S3, Table S3). Therefore, N357 was identified as (2S)-2-(6-methoxy-2-

249

naphthyl) propanoyl-L-glutamine (Gln-naproxen). Similarly, the accurate m/z of N358 (m/z

250

358.2609, tR = 10.0 min) allowed the prediction of a chemical formula C19H21NO6 at 4.46 ppm,

11


Page 12 of 42

Page 13 of 42


251

with ∆abundance of [M+1-H] at 0.39%. The metabolite N358 produced fragments at m/z 185,

252

170, 146, 128, 102, and 84, which were in agreement with the characteristic fragmentation

253

pattern of naproxen and glutamic acid in the present study and in the database (Table 1, Table S3,

254

and Figure S4). Consequently, N358 was identified as (2S)-2-(6-methoxy-2-naphthyl)

255

propanoyl-L-glutamic acid (Glu-naproxen). The structures of Gln-naproxen and Glu-naproxen

256

were further confirmed by comparing retention times and mass spectra against the authentic

257

standards (Text S2 and Figure S5). Thus, Gln-naproxen and Glu-naproxen also achieved Level 1

258

unambiguous confirmation as “confirmed” structures.33

259

The identification of the other 8 metabolites achieved Level 2a confirmation as

260

“probable” structures by applying the above criteria and analysis of fragmentation patterns.33 In

261

brief, N486 was identified as (2S)-2-(6-methoxy-2-naphthyl) propanoyl-L-α-glutamyl-L-

262

glutamine (GluGln-naproxen) (Table 1, Text S2), N401 as (2S)-2-(6-methoxy-2-naphthyl)

263

propanoyl-L-α-anlanyl-L-threonine (ThrAla-naproxen), N429 as (2S)-2-(6-methoxy-2-naphthyl)

264

propanoyl-L-α-anlanyl-L-glutamic acid (GluAla-naproxen) (Figure S4), and N457 as (2S)-2-(6-

265

methoxy-2-naphthyl) propanoyl-L-α-glutamyl-L-valine (ValGlu-naproxen) (Table 1). The

266

metabolites N471-a and N471-b were identified as (2S)-2-(6-methoxy-2-naphthyl) propanoyl-L-

267

α-glutamyl-L-isoleucine (IleGlu-naproxen) and (2S)-2-(6-methoxy-2-naphthyl) propanoyl-L-α-

268

glutamyl-L-leucine (LeuGlu-naproxen), respectively. The metabolite N505 was identified as

269

(2S)-2-(6-methoxy-2-naphthyl) propanoyl-L-α-glutamyl-L-phenylalanine (PheGlu-naproxen),

270

and N563 as (2S)-2-(6-hydroxy-2-naphthyl) propanoyl-L-α-glutaminylglycyl-L-tyrosine

271

(TyrGlyGln-DMnaproxen) (Table 1, Text S2, Table S1, Figure S6).

272 273

Finally, N477 (m/z 477.0562, tR =7.2min) showed a predicted formula C19H17N4O7S2 with a mass error of 3.84 ppm. However, the fragments were not adequately explained and

12



274 275

therefore it remained as an “unknown” structure in this study (Table 1). Phase I and II Transformations of Naproxen. Analysis of primary metabolites clearly

276

showed that direct conjugation of naproxen with amino acids or peptides was a major route for

277

naproxen biotransformation in A. thaliana cells, accounting for >90% of the metabolites detected

278

after 120 h of cultivation (Figures 2 and 3). In view of the confirmed and probable

279

transformation intermediates, their abundance over time, and known plant auxin amino acid

280

pathways,34 three tentative transformation pathways depicting Phase I and II metabolism are

281

proposed (Figure 2). Briefly, naproxen parent undergoes direct conjugation with Glu to form

282

Glu-naproxen (N358) and further conjugation with an additional amino acid to form dipeptide

283

conjugates, i.e., ValGlu-naproxen (N457), IleGlu-naproxen (471-a), LeuGlu-naproxen (N471-b),

284

GluGln-naproxen (N486), or PheGlu-naproxen (N505). In addition, naproxen may also

285

conjugate directly with Gln, forming Gln-naproxen (N357) or undergo demethylation to form

286

DMnaproxen. These two metabolites may then undergo multi-step reactions, e.g., demethylation

287

and amino acid conjugation, to form the tripeptide conjugates, i.e., TyrGlyGln-DMnaproxen

288

(N563) (Figure 2). Interestingly, Gln-naproxen (N357) disappeared quickly from the cells, while

289

Glu-naproxen (N358) increased concurrently (Figures 3 and S6), suggesting that Gln-naproxen

290

may have been oxidized to Glu-naproxen. Additionally, naproxen may also conjugate with

291

peptides L-α-alanyl-L-threonine and L-α-alanyl-L-glutamic acid to form ThrAla-naproxen

292

(N401) and GluAla-naproxen (N429), respectively. The amounts of all metabolites tended to

293

decrease over time, except for Glu-naproxen (N358) or ThrAla-naproxen (N401) (Figures S7 and

294

S8), suggesting that some conjugates were further converted or incorporated into cell matter.

295 296

Throughout the incubation, the relative fraction of Glu-naproxen (N358) increased, and that of Gln-naproxen (N357) decreased, while naproxen and the other metabolites remained at

13


Page 14 of 42

Page 15 of 42


297

similar levels over time (Figure 3). As reference standards were not available for all metabolites,

298

it was impossible to accurately evaluate the abundance of the conjugates in the cell extracts.

299

However, given their generally similar core structures and the use of identical analytical

300

conditions, the kinetics of formation and accumulation of these metabolites may be regarded as

301

semi-quantitative.30 These metabolites were also observed in the whole plant of Arabidopsis (Col-0 and Ler-

302 303

0). The concentrations of naproxen, Glu-naproxen and Gln-naproxen in Arabidopsis seedlings

304

after 4 d of cultivation were 3.5 ± 0.9, 3.2±1.0, and 1.5 ± 0.4 mg kg-1, respectively, for

305

Arabidopsis Col-0 and 1.8 ± 0.0, 4.6 ± 0.6, and 4.4 ± 1.3 mg kg-1, respectively, for Arabidopsis

306

Ler-0.

307

To the best of our knowledge, this is the first observation that conjugation of the parent

308

molecule with amino acids, instead of demethylation, glucuronidation, or sulfation, contributed

309

largely to the metabolic fate of naproxen in plants. The amino acid conjugates of naproxen and

310

its metabolite demethyl-naproxen were previously observed only in animals and microorganisms,

311

where the glycine conjugate was the most frequently observed, while the glucuronide conjugate

312

was the most dominant.35–40

313

Mass Balance and Phase III Compartmentation of Naproxen. To elucidate the full

314

metabolic fate of naproxen in plant cells, 14C labeled naproxen was used to quantitatively track

315

the incorporation of naproxen and its metabolites into cell matter. Figure 4 shows the dissipation

316

of extractable residues, formation of non-extractable residue and the overall mass balance of 14C

317

radioactivity. The overall mass balance ranged from 89±2 to 100±5% throughout the incubation,

318

suggesting good recoveries using the sample preparation protocol (Figure 4). The total

319

radioactivity in system did not change appreciably over time, implying that there was negligible

14



320

loss due to volatilization of naproxen or its metabolites (e.g., 14CO2), or adsorption to container

321

surfaces. At the end of incubation, the extractable residues were 74.2 ± 0.6% of the initial spiked

322

14

C activity. The non-extractable residue quickly increased to 11.1 ± 1.7% at 6 h and further to

323

21.7 ± 3.4% at 24 h, and then gradually decreased to 11.0 ± 0.7% at 120 h. Therefore, non-

324

extractable residue was a relatively small fraction of the total radioactivity. This finding was

325

similar to that for the herbicide 2,4-D (also a carboxylic acid as naproxen) in soybean (Glycine

326

max L.) and wheat (Triticum aestivum L.) cells.41,42

327

Direct Conjugation of Ibuprofen. To test whether other profens undergo similar

328

transformation pathways in Arabidopsis, we exposed Arabidopsis cells to ibuprofen and

329

identified metabolites in a similar manner as for naproxen. The results showed that ibuprofen

330

underwent very similar transformation reactions to naproxen. For example, ibuprofen parent

331

conjugated directly with Gln or Glu to form Gln-IBP (IBP333, confirmed structure) or Glu-IBP

332

(IBP334, confirmed structure) (Figure S9, Text S2). In addition, ibuprofen was hydroxylated to

333

OH-IBP, which subsequently conjugated with Glu, Gln, and Ser to form 2-OH-Glu-IBP

334

(IBP350a), 3-OH-Glu-IBP (IBP350b), OH-Gln-IBP (IBP349), and OH-Ser-IBP (IBP308)

335

(Figure S9, Table S4). These results, together with findings for naproxen, clearly show that

336

conjugation with amino acids, especially Glu and Gln, was a major route of biotransformation of

337

profens in Arabidopsis.

338

It must be noted that to facilitate the identification of metabolites,21,22 relatively high

339

concentrations of naproxen and ibuprofen were used in both the cell cultivation and whole plant

340

hydroponic experiments. For instance, the concentration of naproxen or ibuprofen in wastewater

341

effluents usually does not exceed the low µg/L level. However, when treated wastewater is used

342

to irrigate a field, it is likely that water evaporates or leaches below the root zone, rendering the

15


Page 16 of 42

Page 17 of 42


343

actual concentration of chemicals in the soil porewater higher than that in the irrigation water.

344

The root zone enrichment may further increase with repeated water applications. On the other

345

hand, studies show that plant transformation of xenobiotics (e.g., 2-mercaptobenzothiazole in

346

Arabidopsis) followed a similar kinetics at different concentrations. The dependence of

347

naproxen or ibuprofen biotransformation kinetics on the treatment concentrations was

348

unfortunately not evaluated in this study. Future research should consider field relevant

349

concentrations to obtain realistic plant accumulation data and refine potential dietary exposure

350

assessment.

351 352 353

DISCUSSION This study represents the first attempt to explore the metabolic fate of commonly used

354

profen drugs in plants by considering especially the formation of conjugates. The results clearly

355

showed that plant metabolites of naproxen or ibuprofen differed from that in other biota such as

356

microorganisms,43 fish,39 rodents,44 and humans.35,45 Demethylation, and conjugation with

357

glucuronic acid, sulfate, or glycine accounted for the major biotransformation routes of naproxen

358

in animals and microorganisms.38,39,44,46 Surprisingly, even though they were targeted for

359

analysis, there was no glucuronide conjugate of naproxen or ibuprofen detected in this study. In

360

contrast, a series of amino acid and peptide conjugates of the parent compound were identified in

361

the present study as the primary phase II metabolites of naproxen or ibuprofen in Arabidopsis

362

(Figure 2 and 5, Table S4 and Table S5). This observation was consistent with LeFevre et al. who

363

found several amino acid conjugates of 2-mercaptobenzothiazole27 and benzotriazole47 in

364

Arabidopsis, while no glucuronide conjugate was detected. In addition, glutamine and glutamate

365

also conjugated with hydroxyl-ibuprofen. These findings together suggest that conjugation with

16



366 367

glutamic acid and glutamine is a common pathway for profens in Arabidopsis. Amino acid and dipeptide conjugates of other carboxylic acids have been previously

368

observed in insects, rodents, birds, mammals, and human, but this transformation route is

369

considered an “unusual” pathway in plants.48–50 For example, conjugates of carboxylic acids with

370

alanine, aspartic acid, arginine, serine, histidine, glutamic acid, glycine, glutamine, aspartic acid,

371

tryptophan, and taurine, as well as several dipeptides (i.e. glycyltaurin, glycylglycin,

372

aspartylserine, glycylvaline) have been reported in different animal species such as spiders,

373

houseflies, millipede, peripatus, rat, mouse, hamster, pigeon, hen, mallard, duck, bat, cow, horse,

374

cat, dog, and humans (Table S5 and Figure S10).48,51–53 In comparison, only sporadic studies

375

have shown amino acid conjugates of carboxylic acids in plants. Staswick et al.24 characterized

376

the conjugates of a plant auxin, indole-3-acetic acid (IAA), with Ala, Asp, Phe, and Trp in A.

377

thaliana seedlings. Feung et al.41 and Witham et al.42 studied the metabolism of the carboxylic

378

acid herbicide 2, 4-D in soybean callus tissue cultures. Seven amino acid conjugates were found,

379

with 2,4-D-Glu and 2,4-D-Asp as the major conjugates.41,42 In addition, the metabolic fate of 2,4-

380

D in plant cell cultures was found to be similar to that in whole plants, suggesting that

381

biotransformation in cells closely reflects the biotransformation pathways in intact plants.54

382

Findings from the previous studies and the current study together suggest that amino acid

383

conjugation is likely a common transformation pathway of carboxylic acids in plants.

384

Amino acid conjugation differs from glucuronidation or sulfation, as it involves one of

385

the various adenosine triphosphate (ATP)-dependent acid: CoA synthetases and acyl-CoA: amino

386

acid N-acyltransferases. The initial step in both xenobiotic and bile acid conjugation involves

387

activation of the carboxyl group to the reactive intermediate acyl-CoA, which is then transferred

388

to an amino acid residue.48,49 The most obvious physicochemical parameter potentially useful in

17


Page 18 of 42

Page 19 of 42


389

determining conjugation is probably the pKa value of the carboxylic acid. The data for three

390

monochlorobenzoic acid derivatives indicated that the extent of glycine conjugation increased

391

with pKa and a change of ca. 1 pKa unit resulted in a 10- to 12-fold increase in glycine

392

conjugation.48 However, for compounds with a narrower range of pKa values, the position of

393

substitution is of greater importance.48,55 In addition to the substitution position, steric hindrance

394

may also be a determining factor in amino acid conjugation. For example, examination of the

395

ortho-substituted benzoic acids showed that chlorine, nitro, and methyl groups may have

396

stronger steric hindrance than the other moieties such as hydrogen and amino group.48

397

Furthermore, the conjugation pattern differed between isomers 1- and 2-naphthylacetic acids,

398

where 1-naphthylacetic acid conjugated preferentially with glucuronic acid and glycine, whereas

399

2-naphthylacetic acid conjugated favorably with glutamine, taurine, and glycine (Table S5).56

400

Indeed, naproxen and ibuprofen, analogous to 2-naphthylacetic acid, were found to be

401

preferentially conjugated with glutamine in Arabidopsis at the beginning of incubation. The

402

decrease of glutamine conjugate of naproxen (Figure S7) after 6 h may be due to further

403

conversions, e.g., to glutamate conjugate via oxidation (Figure 2). It must be noted that naproxen

404

(pKa = 4.2) and ibuprofen (pKa = 4.6) have very similar pKa values, and differences in their

405

conjugate formation may be attributable more to differences in their substitutions.57 Such

406

structural effects should be considered in future research to establish quantitative structure-

407

activity (QSAR) relationships, such as for the profens that all contain a propionic acid group with

408

different substitutions.

409

The predominance of certain amino acid conjugates observed in this and previous studies

410

may be due to the abundance and substrate specificity of enzymes in Arabidopsis that catalyze

411

these reactions.24,58 Staswick et al.,24 Westfall et al.,59 and Peat et al.60 systematically identified

18



412

and characterized an Arabidopsis enzyme family, i.e., indole-3-acetic acid (IAA).

413

amidosynthetase (GH3), for conjugating IAA with various amino acids. Among the 19 GH3

414

proteins from Arabidopsis, GH3.5, GH3.2, GH3.12 and GH3.17 appeared to favor Glu over

415

other amino acids under in vitro reaction conditions.24,59 In addition, benzoate and 1-

416

naphthaleneacetic acid (NAA), structurally similar to naproxen, were found to have affinity for

417

the active site of GH3 proteins.24,60,61 These mechanistic studies, together with our results, show

418

that the GH3 enzyme family in plants may have a significant role in catalyzing the conjugation

419

of carboxylic acid compounds such as profens in plants. It is likely that differences in enzyme

420

types or their abundance may contribute to variations among plant species for their ability to

421

carry out these conjugation reactions.

422

Phase II reactions, i.e., glucuronidation, sulfation, and amino acid conjugation, are

423

generally considered detoxification pathways in animals, since the conjugates may be excreted

424

via urine and bile. However, conjugates in plant tissues may lead to underestimation of human

425

exposure, if such conjugates are deconjugated in plants or after human intake. Although it is

426

unclear how amino acid conjugates of naproxen or ibuprofen are regulated in plants, there is

427

evidence showing that glutamate conjugate of indole acetic acid (IAA-Glu) is not appreciably

428

hydrolyzed compared to other amino acid (e.g., leucine, alanine) conjugates of IAA in

429

Arabidopsis seedlings.34 In addition, human gut microbiota, enterocytes, and hepatocytes are

430

known to express enzymes such as aminoacylases, dipeptidases and glucuronidases that may

431

cleave conjugates.15,62–68 For instance, amino acid conjugates of salicylic acid were stable in the

432

upper gastrointestinal tract, but were hydrolyzed in the colon to release the active parent salicylic

433

acid.68 Glycine conjugate of naproxen was found to exhibit 78.5% reversion to naproxen by fecal

434

content in vitro.69 In general, the deconjugation rate of amino acid conjugates varied from 52.6%

19


Page 20 of 42

Page 21 of 42


435

to 96.5%.64,66,68–70 Indeed, the daily intake of naproxen, if estimated by considering the

436

conjugation fraction in Arabidopsis seedlings and deconjugation rates, would be 752 ng/kg body

437

weight/day, using the same input values as in Prosser and Sibley.71 The calculated adult hazard

438

quotient would become 0.11, which is 11 times larger than that derived solely from the parent

439

compound (Text S3).71

440

The metabolite-parent back transformation was also found for other biologically active

441

compounds such as steroidal growth promoters72 and anticancer drugs.63 In some cases,

442

hydrolysis of conjugates and the following release of the active compound may be even fatal.63

443

Irinotecan, a potent antineoplastic prodrug in clinical use, was metabolized to an active

444

metabolite, SN-38, which conjugates with glucuronic acid by the liver to form SN-38-

445

glucuronide and then excreted into the colon via bile. The SN-38-gluruconide then served as a

446

substrate for gut microbial glucuronidase, producing active metabolite SN-38, which caused

447

severe diarrhea.63

448

While the release of parent or metabolites in the free form may be a source of

449

exposure,64,73 the amino acid conjugates themselves may also confer toxicological effects.69,74

450

For example, a variety of amino acid conjugates of naproxen and ibuprofen were found to have

451

similar biological activity to the parent in vivo in rats.74 The glycine/glutamine conjugates of

452

several other carboxylic acids also showed acute toxicity to mice or rat that was comparable to

453

that of the parent on a molar basis.48,75 This preservation and/or enhancement of reactivity or

454

toxicity has also been observed for various conjugates arising from acetylation, glucuronidation,

455

and glutathione conjugation.48 However, little is known about the biological activity of amino

456

acid conjugates of plant origin. Given the dominance of amino acid conjugates as observed for

457

naproxen and ibuprofen, it is possible that the other profens or carboxylic acids may undergo a

20



458

similar transformation process. Thus, it is imperative to conduct further research to understand

459

the toxicological consequence of amino acid conjugates of such CECs from plant matrices.

460

Findings from this study showed that naproxen and ibuprofen were quickly metabolized

461

to produce a range of metabolites in Arabidopsis cells. The parent form of naproxen or ibuprofen

462

was only a negligible fraction of the chemical mass in Arabidopsis cells after 48 h. As many as

463

10 monoamino acid or peptide conjugates were confirmed or tentatively identified for naproxen,

464

of which the primary conjugates were Gln-naproxen (N357) and Glu-naproxen (N358). A similar

465

pattern was also observed for ibuprofen. The conjugates of amino acids and the parent compound

466

were also detected in whole plants of Arabidopsis. Given the importance of amino acid

467

conjugation in the plant metabolism of naproxen and ibuprofen, and that such conjugates are

468

potentially biologically active either before or after cleavage, risk assessment based on the

469

monitoring of the parent compound alone may lead to underestimations. Therefore, improved

470

risk assessment of human exposure to these compounds through practices such as wastewater

471

irrigation and solid waste reuse in agriculture should take plant biotransformation and conjugates

472

into consideration.

473

As many CECs similarly carry a carboxylic group, conjugation with amino acids may be

474

a common pathway for plant metabolism of a wide range of man-made chemicals. Further

475

research is needed to evaluate the biological activity of conjugates of CECs of plant origin and to

476

characterize the dependence of such conjugation on chemical structures as well as plant species.

477

Field and clinical observations targeting such conjugates in food produce may offer information,

478

enabling realistic risk predictions for practices, such as the use of treated wastewater, biosolids

479

and animal wastes in agriculture.

480

21


Page 22 of 42

Page 23 of 42


481

Supporting Information

482

Additional details on descriptions of cell culture medium, metabolite identification, human

483

health risk calculation, and mass spectral information of naproxen and ibuprofen metabolites.

484

This material is available free of charge via the Internet at http://pubs.acs.org.

485 486

Corresponding Author:

487

*Phone: 951-827-2712; fax: 951-827-3993; e-mail: [email protected].

488 489

ACKNOWLEDGMENTS. We appreciate Mr. Ron New for assistance in instrumental analysis.

490

This research was supported by the U.S. Environmental Protection Agency (Grant No.

491

83582901).

492 493

REFERENCES

494

(1)

Wu, X.; Conkle, J. L.; Ernst, F.; Gan, J. Treated wastewater irrigation: uptake of

495

pharmaceutical and personal care products by common vegetables under field conditions.

496

Environ. Sci. Technol. 2014, 48 (19), 11286–11293.

497

(2)

2012; Vol. 26.

498 499

(3)

United States Environmental Protection Agency. Biosolids generation, use, and disposal in the United States; Washington DC, 1999.

500 501

US Environmental Protection Agency. Guidelines for Water Reuse; Washington, D.C.,

(4)

Boxall, A.; Rudd, M. A.; Brooks, B. W.; Caldwell, D. J.; Choi, K.; Hickmann, S.; Innes,

502

E.; Ostapyk, K.; Staveley, J. P.; Verslycke, T.; et al. Pharmaceuticals and personal care

503

products in the environment: what are the big questions? Environ. Heal. Perspect. 2012,

22



120 (9), 1221–1229.

504 505

(5)

Carter, L. J.; Harris, E.; Williams, M.; Ryan, J. J. .; Kookana, R. S. .; Boxall, A. B. A. Fate

506

and uptake of pharmaceuticals in soil-plant systems. J. Agric. Food Chem. 2014, 62 (4),

507

816–825.

508

(6)

of triclosan and triclocarban. Water Res. 2016, 102, 117–124.

509 510

Fu, Q.; Wu, X.; Ye, Q.; Ernst, F.; Gan, J. Biosolids inhibit bioavailability and plant uptake

(7)

Malchi, T.; Maor, Y.; Tadmor, G.; Shenker, M.; Chefetz, B. Irrigation of root vegetables

511

with treated wastewater: evaluating uptake of pharmaceuticals and the associated human

512

health risks. Environ. Sci. Technol. 2014, 48 (16), 9325–9333.

513

(8)

Wu, C.; Spongberg, A. L.; Witter, J. D.; Fang, M.; Czajkowski, K. P. Uptake of

514

pharmaceutical and personal care products by soybean plants from soils applied with

515

biosolids and irrigated with contaminated water. Environ. Sci. Technol. 2010, 44 (16),

516

6157–6161.

517

(9)

Schwitzguebel, J. P.; Vanek, T. Some fundamental advances for xenobiotic chemicals. In

518

Phytoremediation: transformation and control of contaminants; McCutcheon, S. C.,

519

Schnoor, J. L., Eds.; John Wiley & Sons: New Jersey, 2004; Vol. 121, pp 123–124.

520

(10)

Liu, J.; Hu, D.; Jiang, G.; Schnoor, J. L. In vivo biotransformation of 3,3′,4,4′-

521

tetrachlorobiphenyl by whole plants-poplars and switchgrass. Environ. Sci. Technol. 2009,

522

43 (19), 7503–7509.

523

(11)

carrot cell cultures. Environ. Pollut. 2016, 211, 141–147.

524 525 526

Wu, X.; Fu, Q.; Gan, J. Metabolism of pharmaceutical and personal care products by

(12)

Bartha, B.; Huber, C.; Schröder, P. Uptake and metabolism of diclofenac in Typha latifolia – how plants cope with human pharmaceutical pollution. Plant Sci. 2014, 227,

23


Page 24 of 42

Page 25 of 42


12–20.

527 528

(13)

followed by glucose conjugation. J. Hazard. Mater. 2012, 243, 250–256.

529 530

Huber, C.; Bartha, B.; Schröder, P. Metabolism of diclofenac in plants – Hydroxylation is

(14)

Wang, S.; Cao, S.; Wang, Y.; Jiang, B.; Wang, L.; Sun, F.; Ji, R. Fate and metabolism of

531

the brominated flame retardant tetrabromobisphenol A (TBBPA) in rice cell suspension

532

culture. Environ. Pollut. 2016, 214, 299–306.

533

(15)

Weinheim, Germany, 2003.

534 535

(16)

Cleuvers, M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59 (3), 309–315.

536 537

Testa, B.; Mayer, J. M. Hydrolysis in drug and prodrug metabolism; Wiley-VCH

(17)

Jelic, A.; Gros, M.; Ginebreda, A.; Cespedes-Sánchez, R.; Ventura, F.; Petrovic, M.;

538

Barcelo, D. Occurrence, partition and removal of pharmaceuticals in sewage water and

539

sludge during wastewater treatment. Water Res. 2011, 45 (3), 1165–1176.

540

(18)

Blair, B. D.; Crago, J. P.; Hedman, C. J.; Klaper, R. D. Pharmaceuticals and personal care

541

products found in the Great Lakes above concentrations of environmental concern.

542

Chemosphere 2013, 93 (9), 2116–2123.

543

(19)

Tixier, C.; Singer, H. P.; Oellers, S.; Muller, S. R. Occurrence and fate of carbamazepine,

544

clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ.

545

Sci. Technol. 2003, 37 (6), 1061–1068.

546

(20)

Eslami, A.; Amini, M.; Yazdanbakhsh, A.; Rastkari, N.; Mohseni-Bandpei, A.; Nasseri,

547

S.; Piroti, E.; Asadi, A. Occurrence of non-steroidal anti-inflammatory drugs in Tehran

548

source water, municipal and hospital wastewaters, and their ecotoxicological risk

549

assessment. Environ. Monit. Assess. 2015, 187 (12), 1–15.

24



550

(21)

Verlicchi, P.; Al Aukidy, M.; Galletti, A.; Petrovic, M.; Barceló, D. Hospital effluent:

551

Investigation of the concentrations and distribution of pharmaceuticals and environmental

552

risk assessment. Sci. Total Environ. 2012, 430, 109–118.

553

(22)

Gómez, M. J.; Petrović, M.; Fernández-Alba, A. R.; Barceló, D. Determination of

554

pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid

555

chromatography–tandem mass spectrometry analysis in hospital effluent wastewaters. J.

556

Chromatogr. A 2006, 1114 (2), 224–233.

557

(23)

Wu, X.; Ernst, F.; Conkle, J. L.; Gan, J. Comparative uptake and translocation of

558

pharmaceutical and personal care products (PPCPs) by common vegetables. Environ. Int.

559

2013, 60, 15–22.

560

(24)

Staswick, P. E.; Serban, B.; Rowe, M.; Tiryaki, I. Characterization of an Arabidopsis

561

enzyme family that conjugates amino acids to indole-3-acetic acid. Plant Cell 2005, 17

562

(2), 616–627.

563

(25)

Kessner, D.; Chambers, M.; Burke, R.; Agus, D.; Mallick, P. ProteoWizard: open source

564

software for rapid proteomics tools development. Bioinformatics 2008, 24 (21), 2534–

565

2536.

566

(26)

Pluskal, T.; Castillo, S.; Villar-Briones, A.; Oresic, M. MZmine 2: modular framework for

567

processing, visualizing, and analyzing mass spectrometry-based molecular profile data.

568

BMC Bioinformatics 2010, 11 (1), 395.

569

(27)

Lefevre, G. H.; Portmann, A. C.; Mu, C. E.; Sattely, E. S.; Luthy, R. G. Plant assimilation

570

kinetics and metabolism of 2- mercaptobenzothiazole tire rubber vulcanizers by

571

Arabidopsis. Environ. Sci. Technol. 2016, 50 (13), 6762–6771.

572

(28)

Rösch, A.; Anliker, S.; Hollender, J. How Biotransformation Influences Toxicokinetics of

25


Page 26 of 42

Page 27 of 42


573

Azole Fungicides in the Aquatic Invertebrate Gammarus pulex. Environ. Sci. Technol.

574

2016, 50 (13), 7175–7188.

575

(29)

Storck, V.; Lucini, L.; Mamy, L.; Ferrari, F.; Papadopoulou, E. S.; Nikolaki, S.; Karas, P.

576

A.; Servien, R.; Karpouzas, D. G.; Trevisan, M.; et al. Identification and characterization

577

of tebuconazole transformation products in soil by combining suspect screening and

578

molecular typology. Environ. Pollut. 2016, 208, Part, 537–545.

579

(30)

Macherius, A.; Eggen, T.; Lorenz, W.; Moeder, M.; Ondruschka, J.; Reemtsma, T.

580

Metabolization of the bacteriostatic agent triclosan in edible plants and its consequences

581

for plant uptake assessment. Environ. Sci. Technol. 2012, 46 (19), 10797–10804.

582

(31)

cells: Rapid formation of conjugates. Environ. Pollut. 2017, 222, 383–392.

583 584

(32)

Silverstein, R. M.; Webster, F. X.; Kiemle, D. J.; Bryce, D. L. Spectrometric identification of organic compounds; John Wiley & Sons, 2014.

585 586

Fu, Q.; Ye, Q.; Zhang, J.; Richards, J.; Borchardt, D.; Gan, J. Diclofenac in Arabidopsis

(33)

Schymanski, E. L.; Jeon, J.; Gulde, R.; Fenner, K.; Ruff, M.; Singer, H. P.; Hollender, J.

587

Identifying small molecules via high resolution mass spectrometry: communicating

588

confidence. Environ. Sci. Technol. 2014, 48, 2097−2098.

589

(34)

95 (5), 707–735.

590 591

Woodward, A. W.; Bartel, B. Auxin: regulation, action, and interaction. Ann. Bot. 2005,

(35)

Sidelmann, U. G.; Bjornsdottir, I.; Shockcor, J. P.; Hansen, S. H.; Lindon, J. C.;

592

Nicholson, J. K.; Grove, U.; Bjørnsdottir, I.; Shockcor, J. P.; Honore, S.; et al. Directly

593

coupled HPLC-NMR and HPLC-MS approaches for the rapid characterisation of drug

594

metabolites in urine: Application to the human metabolism of naproxen. J. Pharm.

595

Biomed. Anal. 2001, 24 (4), 569–579.

26



596

(36)

chronic toxicity studies: Application to naproxen. J. Pharm. Sci. 1973, 62 (6), 937–941.

597 598

Thompson, G. F.; Collins, J. M. Urinary metabolic profiles for choosing test animals for

(37)

Vree, T. B.; van den Biggelaar-Martea, M.; Verwey-van Wissen, C. P. Determination of

599

naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human

600

plasma and urine by means of direct gradient high-performance liquid chromatography. J.

601

Chromatogr. 1992, 578 (2), 239–249.

602

(38)

Andersen, J. V.; Hansen, S. H. Simultaneous quantitative determination of naproxen, its

603

metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples

604

by high-performance liquid chromatography on dynamically modified silica. J.

605

Chromatogr. B Biomed. Sci. Appl. 1992, 577 (2), 325–333.

606

(39)

Brozinski, J.-M.; Lahti, M.; Oikari, A.; Kronberg, L. Detection of naproxen and its

607

metabolites in fish bile following intraperitoneal and aqueous exposure. Environ. Sci.

608

Pollut. Res. Int. 2011, 18 (5), 811–818.

609

(40)

Lahti, M.; Brozinski, J. M.; Jylhä, A.; Kronberg, L.; Oikari, A. Uptake from water,

610

biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ.

611

Toxicol. Chem. 2011, 30 (6), 1403–1411.

612

(41)

Feung, C.-S.; Hamilton, R. H.; Mumma, R. O. Metabolism of 2,4-dichlorophenoxyacetic

613

acid. V. Identification of metabolites in soybean callus tissue cultures. J. Agric. Food

614

Chem. 1973, 21 (4), 637–640.

615

(42)

Witham, F. H.; Feung, C.-S.; Hamilton, R. H. Metabolism of 2,4-dichlorophenoxyacetic

616

acid by soybean cotyledon callus tissue cultures. J. Agric. Food Chem. 1971, 19 (3), 475–

617

479.

618

(43)

Zhong, D.-F.; Sun, L.; Liu, L.; Huang, H.-H. Microbial transformation of naproxen by

27


Page 28 of 42

Page 29 of 42


Cunninghamella species. Acta Pharmacol. Sin. 2003, 24, 442–447.

619 620

(44)

Sanoh, S.; Horiguchi, A.; Sugihara, K.; Kotake, Y.; Tayama, Y.; Uramaru, N.; Ohshita,

621

H.; Tateno, C.; Horie, T.; Kitamura, S.; et al. Predictability of metabolism of ibuprofen

622

and naproxen using chimeric mice with human hepatocytes. Drug Metab. Dispos. 2012,

623

40 (12), 2267–2272.

624

(45)

Aresta, A.; Palmisano, F.; Zambonin, C. G. Determination of naproxen in human urine by

625

solid-phase microextraction coupled to liquid chromatography. J. Pharm. Biomed. Anal.

626

2005, 39, 643–647.

627

(46)

Quintana, J. B.; Weiss, S.; Reemtsma, T. Pathways and metabolites of microbial

628

degradation of selected acidic pharmaceutical and their occurrence in municipal

629

wastewater treated by a membrane bioreactor. Water Res. 2005, 39 (12), 2654–2664.

630

(47)

LeFevre, G. H.; Müller, C. E.; Li, R. J.; Luthy, R. G.; Sattely, E. S. Rapid

631

phytotransformation of benzotriazole generates synthetic tryptophan and auxin analogs in

632

Arabidopsis. Environ. Sci. Technol. 2015, 49 (18), 10959–10968.

633

(48)

Hutt, A. J.; Caldwell, J. Amino acid conjugation. In Conjugation reactions in drug

634

metabolism: an integrated approach; Mulder, G. J., Ed.; CRC Press: London, 2003; pp

635

278–299.

636

(49)

Knights, K. M.; Sykes, M. J.; Miners, J. O. Amino acid conjugation: contribution to the

637

metabolism and toxicity of xenobiotic carboxylic acids. Expert Opin. Drug Metab.

638

Toxicol. 2007, 3 (2), 159–168.

639

(50)

Schröder, P. Exploiting Plant Metabolism for the Phytoremediation of Organic

640

Xenobiotics. In Phytoremediation; Willey, N., Ed.; Methods in Biotechnology; Humana

641

Press: New Jersey, 2007; pp 251–263.

28



642

(51)

Knights, K. M.; Miners, J. O. Amino Acid Conjugation: A Novel Route of Xenobiotic

643

Carboxylic Acid Metabolism in Man. In Encyclopedia of Drug Metabolism and

644

Interactions; Lyubimov, A. V., Ed.; John Wiley & Sons, Inc.: Lancaster, 2011; pp 1–3.

645

(52)

Dixon, P. A. F.; Caldwell, J.; Smith, R. L. Metabolism of Arylacetic Acids: 2. The Fate of

646

[14C] Hydratropic Acid and its Variation with Species. Xenobiotica 1977, 7 (11), 707–

647

715.

648

(53)

Tanaka, Y.; Shimomura, Y.; Hirota, T.; Nozaki, A.; Ebata, M.; Takasaki, W.; Shigehara,

649

E.; Hayashi, R.; Caldwell, J. Formation of glycine conjugate and (–)-(R)-enantiomer from

650

(+)-(S)-2-phenylpropionic acid suggesting the formation of the coa thioester intermediate

651

of (+)-(S)-enantiomer in dogs. Chirality 1992, 4 (6), 342–348.

652

(54)

Feung, C. S.; Loerch, S. L.; Hamilton, R. H.; Mumma, R. O. Comparative metabolic fate

653

of 2,4-dichlorophenoxyacetic acid in plants and plant tissue culture. J. Agric. Food Chem.

654

1978, 26 (5), 1064–1067.

655

(55)

Dixon, P. A. F.; Caldwell, J.; Woods, C. J.; Smith, R. L. Influence of Chemical Structure

656

on the Pattern of Conjugation in vivo and in vitro of Some Arylacetic Acids in the Rat.

657

Biochem. Soc. Trans. 1976, 4 (1), 143–145.

658

(56)

Emudianughe, T. S.; Caldwell, J.; Smith, R. L. Studies on the metabolism of arylacetic

659

acids. 6. Comparative metabolic conjugation of 1-and 2-naphthylacetic acids in the guinea

660

pig, mouse, hamster and gerbil. Xenobiotica 1987, 17 (7), 815–821.

661

(57)

Chiarini, A.; Tartarini, A.; Fini, A. pH-Solubility Relationship and Partition Coefficients

662

for some Anti-Inflammatory Arylaliphatic Acids. Arch. Pharm. (Weinheim). 1984, 317

663

(3), 268–273.

664

(58)

Staswick, P. E.; Tiryaki, I.; Rowe, M. L. Jasmonate Response Locus JAR1 and Several

29


Page 30 of 42

Page 31 of 42


665

Related Arabidopsis Genes Encode Enzymes of the Firefly Luciferase Superfamily That

666

Show Activity on Jasmonic, Salicylic, and Indole-3-Acetic Acids in an Assay for

667

Adenylation. Plant Cell 2002, 14 (6), 1405–1415.

668

(59)

Westfall, C. S.; Zubieta, C.; Herrmann, J.; Kapp, U.; Nanao, M. H.; Jez, J. M. Structural

669

basis for prereceptor modulation of plant hormones by GH3 proteins. Science (80-. ).

670

2012, 336, 1708–1711.

671

(60)

Peat, T. S.; Böttcher, C.; Newman, J.; Lucent, D.; Cowieson, N.; Davies, C. Crystal

672

structure of an indole-3-acetic acid amido synthetase from grapevine involved in auxin

673

homeostasis. Plant Cell 2012, 24 (11), 4525–4538.

674

(61)

Okrent, R. A.; Brooks, M. D.; Wildermuth, M. C. Arabidopsis GH3.12 (PBS3) conjugates

675

amino acids to 4-substituted benzoates and is inhibited by salicylate. J. Biol. Chem. 2009,

676

284 (15), 9742–9754.

677

(62)

August, J. T.; Murad, F.; Anders, M. W.; Dekant, W. Conjugation-dependent

678

carcinogenicity and toxicity of foreign compounds, 1st Edition. In Advances in

679

Pharmacology; Anders, M. W., Dekant, W., Eds.; Academic Press: San Diego, 1994; pp

680

431–448.

681

(63)

Wallace, B. D.; Wang, H.; Lane, K. T.; Scott, J. E.; Orans, J.; Koo, J. S.; Venkatesh, M.;

682

Jobin, C.; Yeh, L.-A.; Mani, S.; et al. Alleviating cancer drug toxicity by inhibiting a

683

bacterial enzyme. Science (80-. ). 2010, 330 (6005), 831–835.

684

(64)

acid in rabbit intestinal microorganisms. J. Pharmacobiodyn. 1985, 8 (12), 989–995.

685 686 687

Shibasaki, J.; Inoue, Y.; Kadosaki, K.; Sasaki, H.; Nakamura, J. Hydrolysis of salicyluric

(65)

Vomvukas, S.; Anders’r, M. W. Bioconversion of prodrugs by conjugate-processing enzymes. Conjug. Carcinog. Toxic. Foreign Compd. 1994, 27, 479–499.

30



688

(66)

Environ. Microbiol. 1977, 33 (1), 15–18.

689 690

(67)

Sinha, V. R.; Kumria, R. Microbially triggered drug delivery to the colon. Eur. J. Pharm. Sci. 2003, 18 (1), 3–18.

691 692

Gilliland, S. E.; Speck, M. L. Deconjugation of bile acids by intestinal lactobacilli. Appl.

(68)

Nakamura, J.; Asai, K.; Nishida, K.; Sasaki, H. A novel prodrug of salicylic acid, salicylic

693

acid-glutamic acid conjugate utilizing hydrolysis in rabbit intestinal microorganisms.

694

Chem. Pharm. Bull. 1992, 40 (8), 2164–2168.

695

(69)

Mishra, A.; Agrawal, S.; Pathak, K. Naproxen glycine conjugate-synthesis,

696

pharmaceutical preformulation and pharmacodynamic evaluation. Drug Deliv. 2012, 19

697

(2), 102–111.

698

(70)

using a targeted prodrug approach. J. Pharm. Pharmacol. 2008, 60 (5), 607–613.

699 700

Philip, A. K.; Dubey, R. K.; Pathak, K. Optimizing delivery of flurbiprofen to the colon

(71)

Prosser, R. S.; Sibley, P. K. Human health risk assessment of pharmaceuticals and

701

personal care products in plant tissue due to biosolids and manure amendments, and

702

wastewater irrigation. Environ. Int. 2015, 75, 223–233.

703

(72)

Qu, S.; Kolodziej, E. P.; Long, S. A.; Gloer, J. B.; Patterson, E. V; Baltrusaitis, J.; Jones,

704

G. D.; Benchetler, P. V; Cole, E. A.; Kimbrough, K. C.; et al. Product-to-Parent Reversion

705

of Trenbolone: Unrecognized Risks for Endocrine Disruption. Science (80-. ). 2013, 342

706

(6156), 347–351.

707

(73)

products. Environ. Sci. Technol. 2003, 37 (20), 4617–4625.

708 709 710

Sinclair, C. J.; Boxall, A. B. A. Assessing the ecotoxicity of pesticide transformation

(74)

Shanbhag, V. R.; Crider, A. M.; Gokhale, R.; Harpalani, A.; Dick, R. M. Ester and amide prodrugs of ibuprofen and naproxen: Synthesis, anti-inflammatory activity, and

31


Page 32 of 42

Page 33 of 42


gastrointestinal toxicity. J. Pharm. Sci. 1992, 81 (2), 149–154.

711 712

(75)

Buly, R. L.; Mumma, R. O. Excretion and metabolism of [(2,4-

713

dichlorophenoxy)acetyl]aspartic acid and [(2,4-dichlorophenoxy)acetyl]valine in the rat. J.

714

Agric. Food Chem. 1984, 32 (3), 571–577.

715

32



716

Figure captions:

717 718

Figure 1. Levels of naproxen in the medium and Arabidopsis thaliana cells. (A) Concentrations

719

of naproxen in the medium cultured with nonviable cells (filled square, ■), no cells (filled

720

triangle, ▲), and viable cells (open circle, ○); and (B) Concentrations of naproxen in viable cells

721

(open diamond, ◊) and nonviable cells (open square, □).

722 723

Figure 2. Proposed formation pathways of naproxen metabolites observed in Arabidopsis

724

thaliana cells based on literature pathways of auxin storage and reactivation. Full chemical

725

names are given in Table 1 for naproxen and its metabolites. Solid line means that phase II

726

metabolites were formed, and dash line indicates that phase I metabolites were formed. Two

727

solid arrow suggests multi-step reactions.

728 729

Figure 3. Kinetics of realtive fractions (%, based on LC-MS/MS peak areas) of naproxen and its

730

metabolites in Arabidopsis thaliana cells during 120-h incubation. Full chemical names are

731

given in Table 1.

732 733

Figure 4. Extractable residue (filled triangle, ▼), bound residue (open triangle, △), and mass

734

balances (open square, □) of 14C-naproxen in Arabidopsis thaliana cell cultures. Error bars

735

represent standard deviation of triplicates. Invisible error bars are in the symbols.

736 737 738 739

33


Page 34 of 42

Page 35 of 42


740

Table 1. Identities of naproxen and its transformation products, and information of high-resolution mass spectra, fragments, retention

741

times, and identification confidence.

742

IDa

tR (min) TOF

m/z measured

Predicted formula [M-H]

m/z calculate d

NPX

11.5

229.0874

C14H13O3

229.0870

N357

9.3

357.1455

C19H21N2O5

357.1456

N358

10.0

358.1312

C19H20NO6

358.1296

N401

9.1

401.1721

C21H25N2O6

401.1718

Error (ppm)

Fragments (m/z)

*185 (naproxen-CO2), 1.7 170 (185-CH3), 169 185 (-Gln-CO), 170 (185-CH3), *145 (Gln), a 128 (Gln-NH2), 0.15 127 (Gln-OH), 109 (145-H2O-NH3), 84 (128-CO2), 74 185 (-Glu-CO), 170 (185-CH3), 146 (Glu), b 4.46 128 (Glu-H2O), *102 (Glu-CO2), 84 (128-CO2) 383 ( 401-H2O), 185 (-AlaThr-CO), 170 (185-CH3), 189 (AlaThr), 0.61 *171 (189-OH), 153 (171-H2O), 141 (171-CH2O), 128 (AlaThr-CO2-OH), 34


Structure proposed

Confidenceb Level 1 (Confirmed)

Level 1 (Confirmed)

Level 1 (Confirmed)

Level 2a (Probable)


N429

9.5

429.1675

C22H25N2O6

N457

10.2

457.1988

C24H29N2O7

N471a

10.8

471.2125

C25H31N2O7

D471b

11.2

471.2141

C25H31N2O7

110 (128-NH3), 86 (Thr-OH-CH3), 84 (128-C2H6N), 185 (-GluAla-CO), 170 (185-CH3), 155 (170-CH3), 429.1667 1.79 300 (+H2O-Glu) 199 (GluAla), *128 (Glu- H2O), *88 (Ala), c 185 (-GluVal-CO), 170 (185-CH3), 395 (-CO2-OH), 341 (-Val), d 297 (341-CO2), 457.1980 1.71 245 (ValGlu), e 228 (245-OH), 201 (228-OH), 184 (228-CO2), *128 (Glu- H2O), 116 (Val) 185 (-GluIle-CO), 128 (Glu-H2O), 457.2137 0.8 241 (GluIle-OH) 130 (Ile), f 185 (-GluLeu-CO), 170 (185-CH3), 128 (Glu-H2O), 457.2137 0.9 241 (GluLeu-OH) 130 (Leu), g

35


Page 36 of 42

Level 2a (Probable)

Level 2a (Probable)

Level 2a (Probable)

Level 2a (Probable)

Page 37 of 42


N486

8.9

486.1885

C24H28N3O8

N505

11.0

505.2003

C28H29N2O7

N563

8.5

563.2145

C29H31N4O8

185 (-GluGln-CO), 170 (185-CH3), *145 (Gln), 128 (Gln-OH/Glu-H2O), 127 (Gln-OH), 109 (145-H2O-NH3), 486.1882 0.63 146 (Glu), 102 (Glu-CO2), 86 (102-O), 274 (GluGln) 257 (274-OH), 239 (257-H2O), 213 (257-CO2), 185 (-PheGlu-CO), 170 (185-CH3), 325 (-Phe-O), 275 (PheGlu-OH), 252 (275-OH), 505.1980 4.5 *164 (Phe), h 147, (Phe-OH) 72 (Phe-Bn), i 128 (Glu-H2O), 109 (128-NH4), 171 (-TyrGlyGln-CO), *351 (TyrGlyGln-NH2), 333 (351-H2O), 383 (-Tyr), 162 (Tyr-OH), 563.2147 0.47 149 (Tyr-OH-NH), 119 (Tyr-CO2-OH), 128 (Gln-NH2), 101 (Gln-CO-NH2), 89, 85, 72,

36


Level 2a (Probable)

Level 2a (Probable)

Level 2a (Probable)


N477

743 744 745 746 747 748 749 750 751 752

7.2

477.0562

C19H17N4O7S2

477.0544

405, 360, 129, 195, 284, 119, 110, 101, 99, *97, 3.84 96, 85, 75,145, 139, 165, 203, 436, 74, 128, 175, 236

a

Page 38 of 42

Unknown structure

Level 3 (Unknown)

List of abbreviations: NPX (naproxen): (2S)-2-(6-methoxy-2-naphthyl)propanoic acid; N357, (2S)-2-(6-methoxy-2naphthyl)propanoyl-L-glutamine; N358, (2S)-2-(6-methoxy-2-naphthyl)propanoyl-L-glutamic acid; N401, (2S)-2-(6-methoxy-2naphthyl)propanoyl-L-α-anlanyl-L-threonine; N429, (2S)-2-(6-methoxy-2-naphthyl)propanoyl-L-α-anlanyl-L-glutamic acid; N457, (2S)-2-(6-methoxy-2-naphthyl)propanoyl-L-α-glutamyl-L-valine; N471-a, (2S)-2-(6-methoxy-2-naphthyl)propanoyl-L-α-glutamyl-Lisoleucine; D471-b, (2S)-2-(6-methoxy-2-naphthyl)propanoyl-L-α-glutamyl-L-leucine; N486, (2S)-2-(6-methoxy-2naphthyl)propanoyl-L-α-glutamyl-L-glutamine; N505, (2S)-2-(6-methoxy-2-naphthyl)propanoyl-L-α-glutamyl-L-phenylalanine; and N563, (2S)-2-(6-hydroxy-2-naphthyl)propanoyl-L-α-glutaminylglycyl-L-tyrosine. b Structure identification confidence was calculated according to Schymanski et al.33 ppm: part per million.

37


Page 39 of 42


753 754

755 756 757

Figure 1.

758 759 760 761 762 763 764

38



765 766 767

Figure 2.

768

39


Page 40 of 42

Page 41 of 42


769

770 771 772

Figure 3.

773 774

40



775

776 777 778

Figure 4.

41


Page 42 of 42

Direct Conjugation of Emerging Contaminants in ... - ACS Publications

Recommend Documents